重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
3期
321-323
,共3页
血浆激肽释放酶%自身免疫疾病%糖尿病%成人隐匿性自身免疫性糖尿病%早期诊断
血漿激肽釋放酶%自身免疫疾病%糖尿病%成人隱匿性自身免疫性糖尿病%早期診斷
혈장격태석방매%자신면역질병%당뇨병%성인은닉성자신면역성당뇨병%조기진단
plasma prekallikrein%autoimmune diseases%diabetes mellitus%latent autoimmune diabetes in adults%early diagnosis
目的:研究血浆激肽释放酶(KLKB1)在成人隐匿性自身免疫性糖尿病(LADA)、经典1型糖尿病(T1DM)、2型糖尿病(T2DM)和健康成人中的水平,并结合其他指标分析其与LADA的关系。方法分别检测LADA组、T1DM组、T2DM组、健康对照组(NC组)血浆样本中KLKB1、糖化血红蛋白(HbA1c)、空腹血糖(FPG)、餐后2h血糖(2hPG)、空腹C肽(FCP)、餐后2hC肽(2hCP)、谷氨酸脱羧酶抗体(GADA)等指标,并对检测结果进行统计学分析。结果LADA组与其他各组在FPG(T2DM组除外)、2hPG、HbA1c、FCP、2hCP指标方面差异有统计学意义(P<0.05)。LADA组与其他各组(T1DM组除外)GADA的差异有统计学意义(P<0.05);KLKB1在LADA组血浆中的含量明显高于T2DM组和NC组,差异有统计学意义(P<0.05);KLKB1与FCP、HbA1c、FPG、2hPG相关(P<0.05),而与年龄、病程、2hCP无关(P>0.05)。ROC曲线进一步分析显示,单独应用KLKB1对LADA进行诊断或鉴别诊断具有一定的局限性。结论KLKB1对判断LADA发病风险和早期诊断LADA有一定意义,可在LADA高危人群中结合其他指标进行LADA的筛选和监控。
目的:研究血漿激肽釋放酶(KLKB1)在成人隱匿性自身免疫性糖尿病(LADA)、經典1型糖尿病(T1DM)、2型糖尿病(T2DM)和健康成人中的水平,併結閤其他指標分析其與LADA的關繫。方法分彆檢測LADA組、T1DM組、T2DM組、健康對照組(NC組)血漿樣本中KLKB1、糖化血紅蛋白(HbA1c)、空腹血糖(FPG)、餐後2h血糖(2hPG)、空腹C肽(FCP)、餐後2hC肽(2hCP)、穀氨痠脫羧酶抗體(GADA)等指標,併對檢測結果進行統計學分析。結果LADA組與其他各組在FPG(T2DM組除外)、2hPG、HbA1c、FCP、2hCP指標方麵差異有統計學意義(P<0.05)。LADA組與其他各組(T1DM組除外)GADA的差異有統計學意義(P<0.05);KLKB1在LADA組血漿中的含量明顯高于T2DM組和NC組,差異有統計學意義(P<0.05);KLKB1與FCP、HbA1c、FPG、2hPG相關(P<0.05),而與年齡、病程、2hCP無關(P>0.05)。ROC麯線進一步分析顯示,單獨應用KLKB1對LADA進行診斷或鑒彆診斷具有一定的跼限性。結論KLKB1對判斷LADA髮病風險和早期診斷LADA有一定意義,可在LADA高危人群中結閤其他指標進行LADA的篩選和鑑控。
목적:연구혈장격태석방매(KLKB1)재성인은닉성자신면역성당뇨병(LADA)、경전1형당뇨병(T1DM)、2형당뇨병(T2DM)화건강성인중적수평,병결합기타지표분석기여LADA적관계。방법분별검측LADA조、T1DM조、T2DM조、건강대조조(NC조)혈장양본중KLKB1、당화혈홍단백(HbA1c)、공복혈당(FPG)、찬후2h혈당(2hPG)、공복C태(FCP)、찬후2hC태(2hCP)、곡안산탈최매항체(GADA)등지표,병대검측결과진행통계학분석。결과LADA조여기타각조재FPG(T2DM조제외)、2hPG、HbA1c、FCP、2hCP지표방면차이유통계학의의(P<0.05)。LADA조여기타각조(T1DM조제외)GADA적차이유통계학의의(P<0.05);KLKB1재LADA조혈장중적함량명현고우T2DM조화NC조,차이유통계학의의(P<0.05);KLKB1여FCP、HbA1c、FPG、2hPG상관(P<0.05),이여년령、병정、2hCP무관(P>0.05)。ROC곡선진일보분석현시,단독응용KLKB1대LADA진행진단혹감별진단구유일정적국한성。결론KLKB1대판단LADA발병풍험화조기진단LADA유일정의의,가재LADA고위인군중결합기타지표진행LADA적사선화감공。
Objective To investigate the plasma expression of plasma prekallikrein(KLKB1)in latent autoimmune diabetes in a‐dults(LADA),type1diabetes(T1DM),type2diabetes(T2DM)andhealthypeople,anditsrelationshipwithLADAincombination with other indicators .Methods Among the four groups ,KLKB1 ,glycosylated hemoglobin(HbA1c) ,fasting blood glucose(FPG) ,2 h postprandial plasma glucose(2 h PG) ,Fasting c‐peptide(FCP) ,2 h postprandial C peptide(2 h CP) ,and glutamic acid decarboxy‐lase antibody(GADA)were detected respectively .And the detection results were analyzed by statistics .Results By comparison , there were statistically significant difference between LADA group and other groups on FPG(except for T2DM group) ,2 h PG , HbA1c ,FCP and 2 h CP(P< 0 .05) .And except for T1DM group ,there was statistically significant difference between LADA group and other groups on GADA ,too(P<0 .05) .The plasma expression of KLKB1 in LADA was significantly higher than those in T2DM group and NC group(P<0 .05) .The levels of KLKB1 was related with FCP、HbA1c、FPG、2 h PG(P<0 .05) ,and it was not related with age ,course ,and 2 h CP(P>0 .05) .Receiver operating characteristic (ROC) showed that only using KLKB1 to di‐agnose LADA had its limitation .Conclusion KLKB1 could be used as a clinical indicator to predict the onset of LADA to a certain degree .We could screen for LADA by using KLKB1 and other indicators in people at high risk .